Free Trial

Amgen (AMGN) Earnings Date, Estimates & Call Transcripts

Amgen logo
$301.44 +2.60 (+0.87%)
(As of 04:40 PM ET)

Amgen Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 4Estimated
Actual EPS
(Oct. 30)
$5.58 Beat By $0.47
Consensus EPS
(Oct. 30)
$5.11

Amgen announced Q3 2024 earnings on October 30, 2024, reporting an EPS of $5.58, which topped the consensus estimate of $5.11 by $0.47. Quarterly revenue rose 23.2% year-over-year to $8.50 billion, above analysts' expectations of $8.50 billion. With a trailing EPS of $7.81 and a P/E Ratio of 38.60, Amgen's earnings are expected to grow 4.15% next year, from $19.51 to $20.32 per share.

AMGN Upcoming Earnings

Amgen's next earnings date is estimated for Tuesday, February 4, 2025, based off prior year's reporting schedules.

Get Amgen Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amgen and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AMGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AMGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Amgen Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244$3.64$4.86$4.10 
Q2 20244$4.85$5.14$5.04 
Q3 20244$4.83$5.23$5.07 
Q4 20244$4.81$5.40$5.09 
FY 202416$18.13$20.63$19.29 
Q1 20252$4.69$5.11$4.90 
Q2 20252$5.07$5.58$5.33 
Q3 20252$5.18$5.95$5.57 
Q4 20252$4.25$5.43$4.84 
FY 20258$19.19$22.07$20.63 
Q1 20261$4.84$4.84$4.84 
Q2 20261$5.20$5.20$5.20 
Q3 20261$5.27$5.27$5.27 

Amgen Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/4/2025
(Estimated)
------- 
10/30/2024Q3 2024$5.11$5.58+$0.47$5.94$8.50B$8.50B        
8/6/2024Q2 2024$5.01$4.97 -$0.04$8.56$8.35B$8.39B        
5/2/2024Q1 2024$3.76$3.96+$0.20$8.13$7.45B$7.45B        
2/6/2024Q4 2023$4.66$4.71+$0.05$8.00$8.13B$8.20B        
10/31/2023Q3 2023$4.65$4.96+$0.31$6.70$6.92B$6.90B        
8/3/2023Q2 2023$4.44$5.00+$0.56$7.43$6.66B$7.00B        
4/27/2023Q1 2023$3.84$3.98+$0.14$2.68$6.18B$6.11B        
2/7/2023Q4 2022$4.04$4.09+$0.05$5.18$6.77B$6.84B          

Amgen Earnings - Frequently Asked Questions

Amgen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates. Learn more on AMGN's earnings history.

Amgen issued an update on its FY 2024 earnings guidance on Wednesday, October, 30th. The company provided earnings per share (EPS) guidance of 19.200-20.000 for the period, compared to the consensus earnings per share estimate of 19.490. The company issued revenue guidance of $33.0 billion-$33.8 billion, compared to the consensus revenue estimate of $33.2 billion.

In the previous quarter, Amgen (NASDAQ:AMGN) reported $5.58 earnings per share (EPS) to beat the analysts' consensus estimate of $5.11 by $0.47. Learn more on analysts' earnings estimate vs. AMGN's actual earnings.

The conference call for Amgen's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Amgen's latest earnings report can be read online.
Read Transcript

Amgen (NASDAQ:AMGN) has a recorded annual revenue of $28.19 billion.

Amgen (NASDAQ:AMGN) has a recorded net income of $6.72 billion. AMGN has generated $7.81 earnings per share over the last four quarters.

Amgen (NASDAQ:AMGN) has a trailing price-to-earnings ratio of 38.76 and a forward price-to-earnings ratio of 15.52. The price/earnings-to-growth ratio is 2.67.

Amgen's earnings are expected to grow from $19.51 per share to $20.32 per share in the next year, which is a 4.15% increase.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:AMGN) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners